• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

My TechDecisions

  • COVID-19 Update
  • Best of Tech Decisions
  • Topics
    • Video
    • Audio
    • Mobility
    • Unified Communications
    • IT Infrastructure
    • Network Security
    • Physical Security
    • Facility
    • Compliance
  • RFP Resources
  • Resources
  • Podcasts
  • Subscribe
  • Project of the Week
  • About Us
    SEARCH
Latest News

UK Medical Device Company Acurable Receives US FDA Clearance for Its Home Sleep Apnea Testing Device AcuPebble SA100

November 30, 2021 TechDecisions Staff

  • Acurable’s first product revolutionizes sleep apnea detection by enabling fully automated and remote testing; saving hours of valuable clinician time and decreasing infection risk by reducing patients’ need to visit hospital
  • The AcuPebble device combines multi-disciplinary innovations in acoustic sensing, electronics and signal processing

LONDON–(BUSINESS WIRE)–AcuPebble SA100, a small wearable device that enables automated, remote home testing to detect obstructive sleep apnea (OSA) in adults, has obtained FDA 510(k) clearance as a Class II medical device in the USA. The device, developed and commercialized by UK-based medical device company Acurable, builds on more than ten years of research led by Professor Esther Rodriguez-Villegas at the Wearable Technologies Lab in Imperial College London.

AcuPebble provides an instant sleep test result including, amongst others, OSA diagnostic indexes equivalent in accuracy to those obtained using the gold standard method – cardiorespiratory polygraphy, which requires time consuming clinical interpretation. The AcuPebble sensor is very small and non-invasive. Simple instructions provided by a companion mobile application guide the patient through their sleep study without any training – creating a seamless patient experience.

AcuPebble devices sense the physiological sounds generated by the body, detecting amongst others, respiratory and cardiac disease biomarkers. Processed acoustic signals are transferred to a mobile device and to the cloud, where patented algorithms extract the parameters doctors need to diagnose or manage conditions such as sleep apnea, COPD and asthma. Automatic processing means that the demand on a clinician’s time is greatly reduced.

OSA is one of the most common serious respiratory disorders, affecting approximately 1 billion people globally.1 The condition causes sufferers to repeatedly stop breathing while sleeping. If left untreated, OSA can lead to serious health complications including high blood pressure, heart attack, type 2 diabetes and dementia. It is also the cause of 25% of road accidents due to tiredness. However, current diagnosis methods are complex, manual and expensive, a problem that AcuPebble sets out to address by making OSA evaluation quick, easy and comfortable for patients and clinicians.

California-based Magnap are using AcuPebble in a sleep apnea clinical trial at the University of California San Francisco. Joseph Lamberti, Lead Engineer at MagNap, said: “AcuPebble SA100 has been a game changer for us as a research tool for patients who are taking part in our clinical trial. The patients love using it, so much so that some have even asked to use it more often than they need to! For the MagNap team, the fact that AcuPebble provides instant results from easy-to-conduct multiple night studies, in a natural sleep setting, is exactly what we need.”

Having obtained FDA clearance, Acurable’s focus over the next two years will be expansion into the US market, where obstructive sleep apnea affects at least 25 million adults.2 The company will open an office in the USA in 2022, and is already working with US healthcare organizations.

Professor Esther Rodriguez-Villegas, inventor of the AcuPebble technology and founder of Acurable, is a world-renowned scientist and has been awarded some of the highest recognitions in her field. She commented: “Sleep apnea is a condition that affects millions of Americans, and diagnostic bottlenecks lead to the majority not having a timely diagnosis. This not only has serious health implications, but results in billions of dollars being spent on avoidable medical costs. Receiving FDA clearance is a major milestone for Acurable and we are very excited to be able to enter the US market to serve the millions living with undiagnosed sleep apnea.”

— ENDS —

References:

  1. Benjafield, A. V., Ayas, N. T., Eastwood, P. R., et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. The Lancet Respiratory Medicine 2019; 7(8): 687–698. doi:10.1016/s2213-2600(19)30198-5.
  2. American Academy of Sleep Medicine. Rising prevalence of sleep apnea in U.S. threatens public health. Available from: https://aasm.org/rising-prevalence-of-sleep-apnea-in-u-s-threatens-public-health/. Accessed November 2021.

 

Contacts

Lewis Picton

lpicton@saycomms.co.uk
+44 (0) 208 971 6419

Nicki Brook

nbrook@saycomms.co.uk
+44 (0)208 971 6426

Images are available upon request.

Related Content:

  • Akumina Announces 86% Year-over-Year SaaS Bookings Growth as…
  • Skykit Survey: Sharing Data Dashboards Broadly with Employees…
  • Insight Cuts Ribbon on New Global Headquarters
  • Keysight Enables AI-LINK to Accelerate 5G Private Network…

Get the FREE Tech Decisions eNewsletter

Sign up Today!

Latest Downloads

Shadow IT
Blueprint Series: How to Reduce Shadow IT

The distributed work model gives employees the flexibility they demand, but it can lead to shadow IT and introduce unnecessary security risk. Resea...

Hybrid Work webinar
Featured Webcast: Collaboration 2.0 — Where Are We Now?

In this webinar, subject matter experts discuss the transformation of the workplace, the rise of hybrid workers, the importance of open connectivit...

guide to end user training cover
Pro Tips for Conducting End User Training

Effective trainings are the glue that can make the difference following a new technology implementation that your team has spent so much time, effo...

View All Downloads

Would you like your latest project featured on TechDecisions as Project of the Week?

Apply Today!
Sharp Microsoft Collaboration HQ Logo

Learn More About the
Windows Collaboration Display

More from Our Sister Publications

Get the latest news about AV integrators and Security installers from our sister publications:

Commercial IntegratorSecurity Sales

AV-iQ

Footer

TechDecisions

  • Home
  • Welcome to TechDecisions
  • Subscribe to the Newsletter
  • Contact Us
  • Media Solutions & Advertising
  • Comment Guidelines
  • RSS Feeds
  • Twitter
  • Facebook
  • Linkedin

Free Technology Guides

FREE Downloadable resources from TechDecisions provide timely insight into the issues that IT, A/V, and Security end-users, managers, and decision makers are facing in commercial, corporate, education, institutional, and other vertical markets

View all Guides
TD Project of the Week

Get your latest project featured on TechDecisions Project of the Week. Submit your work once and it will be eligible for all upcoming weeks.

Enter Today!
Emerald Logo
ABOUTCAREERSAUTHORIZED SERVICE PROVIDERSTERMS OF USEPRIVACY POLICY

© 2022 Emerald X, LLC. All rights reserved.